Dr. Markus Moser, CEO
Dr. Markus Moser is the Chief Executive Officer (CEO) of Prionics. Dr. Moser leads the executive management team and is responsible for the day-to-day leadership and management of the corporation.
In 1997, Dr. Moser founded Prionics together with Dr. Bruno Oesch and Dr. Carsten Korth at the University of Zurich, Switzerland. After having served as Co-CEO with Dr. Oesch, Dr. Moser assumed the responsibility as the sole CEO in May 2007.
Dr. Moser holds a Master's degree in Molecular Biology from the University of Zurich. He later completed his doctoral dissertation on prion diseases at the Brain Research Institute of the University of Zurich. In subsequent years, he was a postdoctoral fellow at the University of Zurich and a guest researcher at the University of Oxford in the UK.
Dr. Moser joined the Prionics Board of Directors in May, 2011.
